London Loves Business, in its coverage of the study, reveals that since 2010, the pharmaceutical industry has been slapped with penalties amounting to $82.8 billion across more than 500 documented cases. These violations encompass issues such as disregarding drug and medical device safety standards, promoting medical products without proper authorization, breaching the False Claims Act, and a range of other transgressions.
Legal on paper, restricted in practice. Inside Germany’s cannabis system, where cultivation is allowed but…
The idea may sound strange: a tobacco plant producing compounds like psilocybin or DMT. Sounds…
The term “addiction” gets thrown around quite freely in everyday language—this is nothing new. Who…
Three days before the Trump administration moved medical marijuana to Schedule III, a new YouGov…
On April 23, 2026, the Trump administration officially moved FDA-approved marijuana products and marijuana products…
Here we are in 2026, and a conflict that was supposed to wrap up in…